Our study provides a novel mechanistic perspective for understanding gene expression programs in the context of AD and suggests a transcriptional link between β-amyloid and tau pathologies, the two hallmark brain lesions that characterize this neurodegenerative condition. Here, MAPT is linked to Alzheimer disease.